SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-17T14:05:37.124354+00:00","dedupe_key":"signal_enriched:news_delta:f948ff4b98c97efa","evidence_event_ids":["evt_1971d386b03c"],"signal_type":"news_headline_delta","source":"news_rss","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPQ203YlF5ZWJkd1Z4dEZ5ZEdQMmpTczdObVh1V3JUUWQxaWViV2pkeXFFZ0hqMy1CWWxQR2RSRHVFN2N4WnF2Y1BzU3gwT3dpRjNuWXVUek96dXdBWTNQRWxDdlQ2OGlmUDRkdWlzR29rYm1sNXluT3BhcEFMT0JMUVpoZksyUDdxcUpsMA?oc=5","as_of":"2026-04-17T14:05:37.124354+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPQ203YlF5ZWJkd1Z4dEZ5ZEdQMmpTczdObVh1V3JUUWQxaWViV2pkeXFFZ0hqMy1CWWxQR2RSRHVFN2N4WnF2Y1BzU3gwT3dpRjNuWXVUek96dXdBWTNQRWxDdlQ2OGlmUDRkdWlzR29rYm1sNXluT3BhcEFMT0JMUVpoZksyUDdxcUpsMA?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_ca68ae0675de6cbd","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-17T21:47:46.117139+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPQ203YlF5ZWJkd1Z4dEZ5ZEdQMmpTczdObVh1V3JUUWQxaWViV2pkeXFFZ0hqMy1CWWxQR2RSRHVFN2N4WnF2Y1BzU3gwT3dpRjNuWXVUek96dXdBWTNQRWxDdlQ2OGlmUDRkdWlzR29rYm1sNXluT3BhcEFMT0JMUVpoZksyUDdxcUpsMA?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"nytimes.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPQ203YlF5ZWJkd1Z4dEZ5ZEdQMmpTczdObVh1V3JUUWQxaWViV2pkeXFFZ0hqMy1CWWxQR2RSRHVFN2N4WnF2Y1BzU3gwT3dpRjNuWXVUek96dXdBWTNQRWxDdlQ2OGlmUDRkdWlzR29rYm1sNXluT3BhcEFMT0JMUVpoZksyUDdxcUpsMA?oc=5","source_event_id":"evt_1971d386b03c","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"74e86e339eabd6d9","published_at":"2026-04-17T09:04:01+00:00","publisher_domain":"nytimes.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.42,"dates_mentioned":[],"entities":[],"event_type":"other","information_gaps":["article_text_unavailable"],"key_facts":["Headline: New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs - The New York Times","Source summary: New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs The New York Times First-of-its-kind Pitt study allows some liver transplant recipients to stop antirejection drugs Pittsburgh Post-Gazette Cell therapy primed liver transplant patients to avoid organ rejection, small study shows statnews.com First-in-human trial primes immune system to accept donor livers Medical Xpress First-Ever Human Trial Trains "],"numeric_claims":[],"primary_claim":"New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs - The New York Times","relevance_score":0.46,"sentiment":"neutral","source_quality":"unknown","summary":"New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs The New York Times First-of-its-kind Pitt study allows some liver transplant recipients to stop antirejection drugs Pittsburgh Post-Gazette Cell therapy primed liver transplant patients to avoid organ rejection, small study shows statnews.com First-in-human trial primes immune system to accept donor livers Medical Xpress First-Ever","topics":["news headline"]},"source":"The New York Times","source_domain":"nytimes.com","source_url":"https://www.nytimes.com","summary":"New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs The New York Times First-of-its-kind Pitt study allows some liver transplant recipients to stop antirejection drugs Pittsburgh Post-Gazette Cell therapy primed liver transplant patients to avoid organ rejection, small study shows statnews.com First-in-human trial primes immune system to accept donor livers Medical Xpress First-Ever Human Trial Trains Immune System to Accept Donor Livers Bioengineer.org","title":"New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs - The New York Times","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 90209 in events